153 390

Cited 0 times in

Immunoassay 신빙도조사 결과보고(2004)

Other Titles
 Annual Report on External Quality Assessment of Immunoassay Subcommittee in Korean Clinical Laboratory Survey (2004) 
Authors
 김현숙  ;  임환섭  ;  김영란  ;  조한수  ;  전혜선  ;  신섭  ;  정영순  ;  권오헌  ;  김덕언  ;  김영기  ;  김진규  ;  선영규 
Citation
 Journal of Laboratory Medicine and Quality Assurance (임상검사와 정도관리), Vol.27(1) : 91-110, 2005 
Journal Title
Journal of Laboratory Medicine and Quality Assurance(임상검사와 정도관리)
ISSN
 2384-2458 
Issue Date
2005
Abstract
Two trials of external quality assessment were performed in 2004 as previous year. Thirteen test items of immunoassay wlth ten control materials were surveyed. The response rate of external quality assessment for immunoassay Subcommittee were 94.4% and 98.6%. Ten control materials were consisted of 8 home-made pooled sera and 2 commercial control sera (LyphoCheck, BioRad, USA). The results are summarized as follows. 1. Laboratories participating in external quality control program of immunoassay were 259 laboratories and the response rate were 94.4% and 98.6% in 2004. 2. Chemiluminiscence immunoassay autoanalyzers were most widely used in the field of immunoassay testing. 3. A new test item CAI25 was introduced in this year from the second trial of external quality survey. 4. Still some test items show big variations of the test results of the same control material according to autoanalyzers. The quality of the participating laboratories seems to be thought being continuously improved. And, some new methods of the statistic analysis and some standardization protocols were considered to be introduced in the surveillance systems.
Files in This Item:
T200501219.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers
Yonsei Authors
Kwon, Oh Hun(권오헌)
Kim, Hyon Suk(김현숙) ORCID logo https://orcid.org/0000-0001-5662-7740
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/151375
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links